Australian biotech is known for its cutting-edge research, robust clinical trial activity, and favourable R&D infras...
Global interest in radiopharmaceuticals has surged in recent years, driven by a string of high-profile deals and rising ...
Day 2 of BIO Asia–Taiwan 2025 unfolded with palpable energy and a heightened sense of purpose as stakeholders from...
Cell and gene therapies are reshaping the landscape of modern medicine—but bringing these transformative treatment...
BioSpectrum Asia spoke to Dr Peter Fedichev, CEO of Gero, who explains how ProtoBind-Diff is transforming drug discovery...
It’s universally acknowledged that Asia-Pacific (APAC) is a hotbed for clinical trials, with multiple reports conf...
As Hong Kong accelerates its transformation into a global biotech and MedTech powerhouse, BioSpectrum ...
Ella Woger-Nieves, Chief Executive Officer of Invest Puerto Rico, spoke to BioSpectrum Asia and BioSpectrum Indi...
As the field shifts toward safer and more efficient gene delivery methods, PlasmidFactory’s proprietary technology...
The biopharma job market has been tough, with widespread downsizing and frequent layoffs across big pharma. But the wors...
Biotech partnerships of APAC differ in a variety of ways from most global collaborations, primarily due to the unique ge...
ICPI Week 2025 Wrap-Up ICPI WEEK 2025 WRAP-UP | BY MANBEENA CHAWLA, EXECUTIVE EDITOR, BIOSPECTRUM ASIA ...
Patients with non-proliferative diabetic retinopathy (NPDR) currently face a therapeutic gap—one that often leaves...
As an infectious diseases’ physician, clinical researcher and microbiologist, I have seen first-hand how new techn...
Biologics have fundamentally altered treatment strategies for a wide array of complex and chronic conditions, thanks to ...
Cloning ServicesPrecise and customized modification of plasmid DNA Replacement of antibiotic resistance genes c...
Asia-Pacific is driving a transformation in the global vaccine supply landscape. According to the WHO Vaccine Report 202...
The offering includes: €850 million floating rate notes, due March 2027, bearing interest at 3-month Eur...
